The Story of Sigma-1R Identification as Potential Drug Target for The Treatment of eIF2B-Leukodystrophy
- Lecturer(s): Prof. Orna Elroy-Stein, Department of Cell Research and Immunology, Faculty of Life Sciences, TAU
- Location: TAU
- Date: Thursday, 14 September 2017
Published in
Related items
-
EXPERT PANEL - Personalized attention and cognitive control training for children with Autism: A potential booster for everyday functioning
-
Personalized attention and cognitive control training for children with Autism: A potential booster for everyday functioning
-
Neuroplasticity in developmental disorders: the specific case of dyslexia
-
Behind the smokescreen of medical cannabis
-
Activity-dependent neuroprotective protein (ADNP) deficiency models synaptic and developmental phenotypes of autism-like syndrome: Toward innovative drug development